Dialysis Filter Improves Kidney Failure Survival Rates
- A new clinical trial led by researchers at London Health Sciences Center Research Institute (LHSCRI) and Western University's Schulich School of medicine & Dentistry is assessing teh Elisio...
- Kidney failure, also known as end-stage renal disease (ESRD), occurs when the kidneys can no longer effectively filter waste and excess fluids from the blood.
- Dialysis uses a filter to perform the functions of healthy kidneys, removing harmful substances.However, conventional dialysis filters may not capture the full spectrum of toxins contributing to the...
“`html
Clinical Trial Evaluates Novel Dialysis Filter for Improved Kidney Failure Outcomes
Table of Contents
A new clinical trial led by researchers at London Health Sciences Center Research Institute (LHSCRI) and Western University’s Schulich School of medicine & Dentistry is assessing teh Elisio HX™ dialysis filter, aiming to enhance the lives of Canadians living with kidney failure.
What is Kidney Failure and why Dialysis Matters
Kidney failure, also known as end-stage renal disease (ESRD), occurs when the kidneys can no longer effectively filter waste and excess fluids from the blood. millions worldwide rely on dialysis as a life-sustaining treatment. According to the Canadian Kidney foundation, over 48,000 canadians are currently receiving dialysis treatment Canadian Kidney Foundation.
Dialysis uses a filter to perform the functions of healthy kidneys, removing harmful substances.However, conventional dialysis filters may not capture the full spectrum of toxins contributing to the complications of kidney failure, impacting patient quality of life.
The Elisio HX™ Filter: A New Approach
Researchers are now evaluating the Elisio HX™ dialysis filter,developed by Nipro, which is designed to remove a wider range of toxins compared to standard filters. This innovative design represents a potential breakthrough in dialysis technology.
The core difference lies in the filter’s enhanced ability to clear uremic toxins – substances that build up in the blood when kidneys fail. These toxins contribute to various health problems, including cardiovascular disease, inflammation, and cognitive decline. By more effectively removing these toxins, the Elisio HX™ filter aims to improve patient outcomes and potentially extend lifespan.
Clinical Trial Details and Canadian Impact
The clinical trial, launched by LHSCRI and Western University’s Schulich School of Medicine & dentistry, is currently underway across Canada. The study will assess the impact of the Elisio HX™ filter on patient health, quality of life, and survival rates. Specific details regarding enrollment criteria and trial locations can be found through LHSCRI London Health Sciences Centre Research Institute.
If successful,the Elisio HX™ filter could become a standard of care for dialysis patients across Canada,offering a critically important betterment in treatment effectiveness and patient well-being.